Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Supplemental Open-Label Arm

NCT06587217 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Parkinsonian Signs in Older Persons

Interventions

DRUG: Carbidopa 25 mg
DRUG: Carbidopa-Levodopa 25/100 mg

Sponsor

University of Michigan

Collaborators

[object Object]